Beam Therapeutics Inc (BEAM) Company Profile & Statistics

Beam Therapeutics Inc
BEAM
(Nasdaq - US)
Closed
28.66
+0.41 (+1.45%)
in:usd•As of: Dec 06, 2023 15:59 UTC -5
After Market:28.8+0.14 (+0.49%)
Open
28.90
High
29.86
Low
28.34

About Beam Therapeutics Inc

CEO

John Evans

Headquarters

238 main street

cambridge, ma 02142, united states

Auditor

Deloitte & Touche LLP

Employees

507

Share Holders

Website

www.beamtx.com

Industry

biotechnology

Sector

health technology

Company Overview

Beam Therapeutics Inc. is a biotechnology company. It engages in developing precision genetic medicines through base editing. Beam Therapeutics Inc. is based in Cambridge, Massachusetts.

Beam Therapeutics Inc Statistics

Valuation Measures

Market Capitalization ²	2.34B
Enterprise Value	2.17B
Enterprise Value/EBITDA (ttm)	-5.32
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	3.01
Price to Sales (ttm)	29.54
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	100.00%
Operating Margin (ttm)	-384.62%
Profit Margin (ttm)	-390.06%
Return on Equity (ttm)	-40.66%
Return on Invested Capital (ttm)	-40.43%
Return on Assets (ttm)	-23.59%

Income Statement

Revenue (ttm)	81.55M
Revenue Per Share (ttm)	1.00
Gross Profit (ttm)	81.55M
EBITDA (ttm)³	-407.23M
Net Income Avi to Common (ttm)	-313.67M
Diluted EPS (ttm)	-4.17

Share Statistics

Beta (5Y Monthly)	1.69
52-Week Change	-35.01%
S&P500 52-Week Change	15.43%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	81.50M
Dividend Yield	0.00%
Float ⁴	77.92M
% Held by Insiders	4.40%
% Held by Institutions	80.64%

Balance Sheet

Total Cash (mrq)	1.02B
Total Cash Per Share (mrq)	12.46
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	4.72%
Quick Ratio (mrq)	4.72%
Book Value Per Share (mrq)	9.81

Cash Flow

Operating Cash Flow Per Share (ytd)	-3.60
Free Cash Flow (ytd)	-314.41M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Beam Therapeutics Inc

Trade With A Regulated Broker